PD-L1/PD-1 presence in the tumor microenvironment and activity of PD-1 blockade in multiple myeloma

被引：167

作者：

Paiva, B. ^{[1
,2
,3
]}

Azpilikueta, A. ^{[2
]}

Puig, N. ^{[4
]}

Ocio, E. M. ^{[4
]}

Sharma, R. ^{[5
]}

Oyajobi, B. O. ^{[5
]}

Labiano, S. ^{[2
]}

San-Segundo, L. ^{[4
]}

Rodriguez, A. ^{[3
]}

Aires-Mejia, I. ^{[4
]}

Rodriguez, I. ^{[2
]}

Escalante, F. ^{[6
]}

de Coca, A. G. ^{[7
]}

Barez, A. ^{[8
]}

San Miguel, J. F. ^{[1
,2
,3
]}

Melero, I. ^{[1
,2
,3
]}

机构：

[1] Univ Navarra Clin, Pamplona, Spain

[2] CIMA, Pamplona, Spain

[3] Inst Invest Sanitaria Navarra IDISNA, Pamplona, Spain

[4] Hosp Univ Salamanca, IBSAL, IBMCC USAL CSIC, Salamanca, Spain

[5] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA

[6] Complejo Hosp Leon, Leon, Spain

[7] Hosp Clin Univ Valladolid, Valladolid, Spain

[8] Hosp Nuestra Senora de Sonsoles, Avila, Spain

来源：

LEUKEMIA | 2015年 / 29卷 / 10期

关键词：

ANTIBODY; EXPRESSION; RESPONSES; CELLS;

D O I：

10.1038/leu.2015.79

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2110 / 2113

页数：5

共 15 条

[1] The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody [J].

Benson, Don M., Jr. ;

Bakan, Courtney E. ;

Mishra, Anjali ;

Hofmeister, Craig C. ;

Efebera, Yvonne ;

Becknell, Brian ;

Baiocchi, Robert A. ;

Zhang, Jianying ;

Yu, Jianhua ;

Smith, Megan K. ;

Greenfield, Carli N. ;

Porcu, Pierluigi ;

Devine, Steven M. ;

Rotem-Yehudar, Rinat ;

Lozanski, Gerard ;

Byrd, John C. ;

Caligiuri, Michael A. .

BLOOD, 2010, 116 (13) :2286-2294

[2] Immunosuppressive Effects of Multiple Myeloma Are Overcome by PD-L1 Blockade [J].

Hallett, William H. D. ;

Jing, Weiqing ;

Drobyski, William R. ;

Johnson, Bryon D. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (08) :1133-1145

[3] Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients [J].

Herbst, Roy S. ;

Soria, Jean-Charles ;

Kowanetz, Marcin ;

Fine, Gregg D. ;

Hamid, Omid ;

Gordon, Michael S. ;

Sosman, Jeffery A. ;

McDermott, David F. ;

Powderly, John D. ;

Gettinger, Scott N. ;

Kohrt, Holbrook E. K. ;

Horn, Leora ;

Lawrence, Donald P. ;

Rost, Sandra ;

Leabman, Maya ;

Xiao, Yuanyuan ;

Mokatrin, Ahmad ;

Koeppen, Hartmut ;

Hegde, Priti S. ;

Mellman, Ira ;

Chen, Daniel S. ;

Hodi, F. Stephen .

NATURE, 2014, 515 (7528) :563-+

[4] Programmed Death Receptor-1/Programmed Death Receptor Ligand-1 Blockade after Transient Lymphodepletion To Treat Myeloma [J].

Kearl, Tyce J. ;

Jing, Weiqing ;

Gershan, Jill A. ;

Johnson, Bryon D. .

JOURNAL OF IMMUNOLOGY, 2013, 190 (11) :5620-5628

[5] Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-γ and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway [J].

Liu, Jizhong ;

Hamrouni, Abdelbasset ;

Wolowiec, Darius ;

Coiteux, Valrie ;

Kuliczkowski, Kazirnierz ;

Hetuin, Dominique ;

Saudemont, Aurore ;

Quesnel, Bruno .

BLOOD, 2007, 110 (01) :296-304

[6] Clinical Development of Immunostimulatory Monoclonal Antibodies and Opportunities for Combination [J].

Melero, Ignacio ;

Grimaldi, Antonio M. ;

Perez-Gracia, Jose L. ;

Ascierto, Paolo A. .

CLINICAL CANCER RESEARCH, 2013, 19 (05) :997-1008

[7] Therapeutic Antitumor Efficacy of Anti-CD137 Agonistic Monoclonal Antibody in Mouse Models of Myeloma [J].

Murillo, Oihana ;

Arina, Ainhoa ;

Hervas-Stubbs, Sandra ;

Gupta, Anjana ;

McCluskey, Brandon ;

Dubrot, Juan ;

Palazon, Asis ;

Azpilikueta, Arantza ;

Ochoa, Maria C. ;

Alfaro, Carlos ;

Solano, Sarai ;

Perez-Gracia, Jose L. ;

Oyajobi, Babatunde O. ;

Melero, Ignacio .

CLINICAL CANCER RESEARCH, 2008, 14 (21) :6895-6906

[8] New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG) [J].

Ocio, E. M. ;

Richardson, P. G. ;

Rajkumar, S. V. ;

Palumbo, A. ;

Mateos, M. V. ;

Orlowski, R. ;

Kumar, S. ;

Usmani, S. ;

Roodman, D. ;

Niesvizky, R. ;

Einsele, H. ;

Anderson, K. C. ;

Dimopoulos, M. A. ;

Avet-Loiseau, H. ;

Mellqvist, U-H ;

Turesson, I. ;

Merlini, G. ;

Schots, R. ;

McCarthy, P. ;

Bergsagel, L. ;

Chim, C. S. ;

Lahuerta, J. J. ;

Shah, J. ;

Reiman, A. ;

Mikhael, J. ;

Zweegman, S. ;

Lonial, S. ;

Comenzo, R. ;

Chng, W. J. ;

Moreau, P. ;

Sonneveld, P. ;

Ludwig, H. ;

Durie, B. G. M. ;

Miguel, J. F. S. .

LEUKEMIA, 2014, 28 (03) :525-542

[9] A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control [J].

Paiva, B. ;

Vidriales, M-B ;

Rosinol, L. ;

Martinez-Lopez, J. ;

Mateos, M-V ;

Ocio, E. M. ;

Montalban, M-A ;

Cordon, L. ;

Gutierrez, N. C. ;

Corchete, L. ;

Oriol, A. ;

Terol, M-J ;

Echeveste, M-A ;

De Paz, R. ;

De Arriba, F. ;

Palomera, L. ;

de la Rubia, J. ;

Diaz-Mediavilla, J. ;

Granell, M. ;

Gorosquieta, A. ;

Alegre, A. ;

Orfao, A. ;

Lahuerta, J-J ;

Blade, J. ;

San Miguel, J. F. .

LEUKEMIA, 2013, 27 (10) :2056-2061

[10] The blockade of immune checkpoints in cancer immunotherapy [J].

Pardoll, Drew M. .

NATURE REVIEWS CANCER, 2012, 12 (04) :252-264

← 1 2 →